SIREN : 834105942
NEGOMAB is a French company founded 8 years ago, specialized in the sector Activités des sièges sociaux. Based in FILLINGES (74250), this company of category PME shows in 2024 a revenue of 339 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2018 |
|---|---|---|---|
| Revenue | 338 517 € | 193 699 € | N/C |
| Net income | 201 728 € | -16 409 € | -17 129 € |
| EBITDA | -18 822 € | -16 842 € | -17 131 € |
| Net margin | 59.6% | -8.5% | N/C |
In 2024, NEGOMAB achieves revenue of 339 k€. Over the period 2023-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +74.8%. Vs 2023, growth of +75% (194 k€ -> 339 k€). After deducting consumption (-2 k€), gross margin stands at 341 k€, i.e. a rate of 101%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -19 k€, representing -5.6% of revenue. Positive scissor effect: EBITDA margin improves by +3.1 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 202 k€, i.e. 59.6% of revenue. This profit can be retained or distributed to shareholders.
338 517 €
340 515 €
-18 822 €
-25 580 €
201 728 €
-5.6%
The debt ratio (= Financial debt / Equity x 100) stands at 169%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 33%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.4 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 61.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
168.601%
33.346%
61.584%
3.376
74.1%
In 2024, the debt ratio of NEGOMAB (168.60) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of NEGOMAB (33.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of NEGOMAB (3.38) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 278.83. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
278.826
-54.776
In 2024, the liquidity ratio of NEGOMAB (278.83) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2024, the interest coverage of NEGOMAB (-54.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 304 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 114 days. The gap of 190 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 343 days of revenue, i.e. 322 k€ to permanently finance.
322 397 €
304 j
114 j
0 j
343 j
Based on 103 transactions of similar company sales in 2024, the value of NEGOMAB is estimated at 843 903 € (range 299 986€ - 2 220 747€). The price/revenue ratio is 0.38x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare NEGOMAB with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of NEGOMAB in 2024 is 339 k€.
Yes, NEGOMAB generated a net profit of 202 k€ in 2024.
The headquarters of NEGOMAB is located in FILLINGES (74250), in the department Haute-Savoie.
The tax return of NEGOMAB is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
NEGOMAB operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.